EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 7,740.00
-150.00 (-1.90%)
Apr 30, 2026, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 256.05 billion as of April 30, 2026. Its market cap has increased by 47.43% in one year.
Market Cap
256.05B
Enterprise Value
352.83B
Revenue
476.94B
Ranking
n/a
PE Ratio
9.22
Stock Price
7,740.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 256.05B, an increase of 636.68%. That is a compound annual growth rate of 40.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 261.02B | 35.80% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 377.93B |
| Anterogen.Co.,Ltd. | 372.23B |
| BINEX | 370.71B |
| HLB Therapeutics | 321.66B |
| Bioneer | 283.14B |
| Genexine | 261.05B |
| JETEMA, | 260.84B |
| MedPacto | 185.09B |